Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice
Daniela Nasteska, Federica Cuozzo, Katrina Viloria, Elspeth M. Johnson, Alpesh Thakker, Rula Bany Bakar, Rebecca L. Westbrook, Jonathan P. Barlow, Monica Hoang, Jamie W. Joseph, Gareth G. Lavery, Ildem Akerman, James Cantley, Leanne Hodson, Daniel A. Tennant, David J. Hodson
Daniela Nasteska, Federica Cuozzo, Katrina Viloria, Elspeth M. Johnson, Alpesh Thakker, Rula Bany Bakar, Rebecca L. Westbrook, Jonathan P. Barlow, Monica Hoang, Jamie W. Joseph, Gareth G. Lavery, Ildem Akerman, James Cantley, Leanne Hodson, Daniel A. Tennant, David J. Hodson
View: Text | PDF
Research Article Endocrinology Metabolism

Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice

  • Text
  • PDF
Abstract

The α-ketoglutarate–dependent dioxygenase, prolyl-4-hydroxylase 3 (PHD3), is an HIF target that uses molecular oxygen to hydroxylate peptidyl prolyl residues. Although PHD3 has been reported to influence cancer cell metabolism and liver insulin sensitivity, relatively little is known about the effects of this highly conserved enzyme in insulin-secreting β cells in vivo. Here, we show that the deletion of PHD3 specifically in β cells (βPHD3KO) was associated with impaired glucose homeostasis in mice fed a high-fat diet. In the early stages of dietary fat excess, βPHD3KO islets energetically rewired, leading to defects in the management of pyruvate fate and a shift from glycolysis to increased fatty acid oxidation (FAO). However, under more prolonged metabolic stress, this switch to preferential FAO in βPHD3KO islets was associated with impaired glucose-stimulated ATP/ADP rises, Ca2+ fluxes, and insulin secretion. Thus, PHD3 might be a pivotal component of the β cell glucose metabolism machinery in mice by suppressing the use of fatty acids as a primary fuel source during the early phases of metabolic stress.

Authors

Daniela Nasteska, Federica Cuozzo, Katrina Viloria, Elspeth M. Johnson, Alpesh Thakker, Rula Bany Bakar, Rebecca L. Westbrook, Jonathan P. Barlow, Monica Hoang, Jamie W. Joseph, Gareth G. Lavery, Ildem Akerman, James Cantley, Leanne Hodson, Daniel A. Tennant, David J. Hodson

×

Figure 5

Metabolic rewiring in βPHD3KO islets during metabolic stress.

Options: View larger image (or click on image) Download as PowerPoint
Metabolic rewiring in βPHD3KO islets during metabolic stress.
(A–C) βPHD...
(A–C) βPHD3KO islets possess intact glucose oxidation (A) but have an impaired accumulation of glycolytic/TCA cycle metabolites (B) and glucose-driven lipogenesis (C) after 4 weeks of HFD (n = 3 islet preparations, 3 animals/genotype; 2-way ANOVA, Benjamini-Krieger-Yekutieli 2-stage procedure). (D) Schematic showing 13C from 13C6-[U]-glucose incorporation into metabolites in βPHD3CON and βPHD3KO islets. (E–I) Mass isotopomer distributions (MID) showing that 13C incorporation from glucose into aspartate (E), glutamate (F), malate (G), fumarate (H), or citrate (I) is similar in SC and HFD βPHD3CON and βPHD3KO islets from animals on either SC or 4 weeks HFD (n = 6 islet preparations, 3 animals/genotype, 2-way ANOVA, Tukey’s test). (J) 13C from 13C6-[U]-glucose is incorporated primarily into m+2 lactate in SC βPHD3CON and βPHD3KO islets, whereas a shift to m+3 lactate is seen during 4 weeks HFD feeding (n = 6 islet preparations, 3 animals/genotype; 2-way ANOVA, Tukey’s test). (K) Steady-state lactate levels are increased in βPHD3KO vs. βPHD3CON islets after 4 weeks HFD (n = 6 islet preparations, n = 3 animals/genotype; 1-way ANOVA, Sidak’s test). (L) Ldha expression is not significantly different in βPHD3CON and βPHD3KO islets from animals on either SC or HFD (n = 8–9 animals/genotype; Dunnett’s test). Data shown as mean ± SEM. *P < 0.05, **P < 0.01, and NS. SC, standard chow; HFD, high-fat diet.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts